When it came to cooperation, everyone's eyes were hot.

Of course, Merck wants to get Ji Sheng's technology, and they are willing to spend more money.

But Ji Sheng definitely didn't want to kill the hen that laid the golden eggs to take the eggs.

The two parties began business negotiations with different purposes.

Roy. Dr. Vagelos, as the current head of Merck, naturally asked him to be the first to speak in a negotiation of this scale, "Mr. Ji, I am very optimistic about this hepatitis B vaccine technology, but I don't know what you think, what benefits you want to get from Merck with this technology, so you can talk about your thoughts first, and I will listen to it." ”

"Yes, you tell us what you think."

"As long as you are sincere enough to hand over this technology to Merck, everything is negotiable."

Alison. Hoin and Liam. Jack and the others said.

This is Joshua. Borg stopped talking, and his task of accompanying Ji Shengqian was basically completed.

Ji Sheng glanced at Joshua. Borg, and then said: "First of all, I want to make an opinion, and that is that I will not sell the patent rights to this technology. ”

Mason. There was a look of disappointment in Randy's eyes.

Roy. Vagelos and the others also knew that Ji Sheng would say this, and they were mentally prepared, but after really hearing it, they couldn't help but smile bitterly, they really wanted to win this technology.

"And how do you want to cooperate?" Roy. Vagelos asked.

Ji Sheng said clearly: "I have two plans. ”

Roy. Vagelos stretched out his hand and said, "Please." ”

Ji Sheng snorted, "The first plan is a long licensing period, I hope to sign a patent license with Merck for more than 20 years, with an annual licensing fee of not less than 100 million US dollars, and I will also get a 25% net profit share, this authorization I will only license to Merck in the beautiful country One company, that is, no other company will compete with Merck for the market share of the hepatitis B vaccine in the beautiful country because of this technology, as for the rest of the world, I will still authorize, can Merck do it better than other companies at that time? It all depends on its own strength, and I would like to add that for some special reasons, if your company chooses this plan, I need Merck to pay a one-time license fee for 20 years, and give me at least 1 billion today, and the remaining 1 billion can be made up slowly. ”

He said that this plan was tantamount to not saying anything.

As long as it is an individual, it will not agree.

It's not that the annual licensing fee of 100 million US dollars is expensive, nor is it that the 25% pure profit sharing requirement is too much, but that the 20-year licensing fee is given at once, and no one is happy, after all, no one knows how fast the development of medicine will be in the future.

Although this is unlikely, it is not impossible.

However, to Ji Sheng's surprise, Roy. After simply discussing with all the Merck executives present, Vagelos raised his head without hesitation and said, "I think this plan is fine." ”

Ji Sheng: "......"

Joshua. Borg: "......"

Neither of them expected Roy. Vagelos was a little dumbfounded when he agreed so simply.

Roy. Vagelos is not a fool, of course he is willing to agree to Ji Sheng's request.

First of all, although Ji Sheng did not say exclusive authorization, but only promised that the beautiful country would not be authorized to other companies, as long as Merck agreed, with its own strong strength, it is easier to quickly seize the global market share, after all, Merck's original old bottom is there, and after discussing with customers, you can replace the old one with the vaccine produced by the new technology.

At that time, even if the rest of the world is licensed, it will still be unable to compete with Merck in the market competition.

This is one reason.

Another very important reason is that even if no one knows how fast the development of medical technology will be in the future, Merck, as the world's largest pharmaceutical company, can analyze that it will take at least ten years to develop a more advanced technology than the hepatitis B vaccine technology brought by Ji Sheng.

Why is Merck so sure?

Very simply, the normal research and development time of a new drug takes six to seven years, which is still the average time, and some drug research and development is even as long as more than ten years, not to mention for the time being, even if someone only spends six to seven years developing a new technology, it is impossible to directly market and sell, which has to go through many links, that is, from a new drug research and development to the successful listing, it will take at least ten years, and the average research and development funds will not be less than 2.6 billion US dollars.

This figure is summed up by Merck and countless people in the pharmaceutical industry, and basically the difference will not be too different.

If Merck gets this technology, how much money can it make in ten years?

In the first two years, Merck earned 12 billion US dollars with their self-developed hepatitis B vaccine technology, with an average annual income of 6 billion, which is still under the premise that there is a competitor Smith Kline must succeed, if they win the technology of Ji Sheng, coupled with their original market share and production line, they will definitely be able to easily put Smith Kline down in the hepatitis B vaccine market share, and it is even possible that the annual net profit will reach more than 10 billion US dollars!

At that time, even if Ji Sheng is given 25% of the net profit share, it will be more than what they are currently earning.

This is one of the advantages, the other advantage is that sales are often bundled, Merck in the development of this new technology to more market share at the same time, will drive the company's other drug sales, then the profit will be immeasurable, geometric rise!

With so many benefits, Roy. Do Vagelos and the rest of Merck's top brass need to hesitate more?

Of course, don't hesitate!

Merck is interested in this technology.

But Ji Sheng didn't think so, the first plan he gave was simply to let Merck have a choice, or to leave himself a way back with hope to get the money today without agreeing to the second request.

He thought about it and hurriedly said, "Don't agree so quickly, do you want to listen to my second plan?" ”

"No, you don't."

"The first option is good."

"Well, we're willing to pay for this technology license."

Merck's top brass have deep pockets.

Ji Sheng was stunned.

Luckily, Roy. Vagelos stretched out his hand to stop everyone from continuing, and he bowed his head slightly: "There is nothing to lose by listening to the second plan, Mr. Ji, let's talk about it." ”

Ji Sheng breathed a sigh of relief and said in an astonishing voice: "The second plan, I don't want a license fee!" ”

"What?" Mason. Randy looked at Ji Sheng in astonishment.

Alison. Hoin's eyes widened all at once.

Even Joshua. Borg couldn't help but look incredulous.

Obviously, no one knows why Ji Sheng obviously has such a technology that can earn high licensing fees, so why he said that he didn't want licensing fees.

Roy. Vagelos was stunned and said, "You don't want a license fee?" ”

"To put it simply, I don't want a direct license fee, just a net profit share, and of course, I have to attach one more condition." Ji Sheng said differently.

Roy. Vagelos couldn't wait to ask, "You say be careful." ”

Ji Sheng said: "My idea is to take 30% of the net profit share, plus you Merck to lend me a billion dollars." ”

A five-percent increase in net profit share would save $100 million a year in licensing fees!

If calculated according to the net profit, Merck has to earn an extra $2 billion a year on the hepatitis B vaccine before it can lose money.

So, is Ji Sheng really so kind to put aside the $100 million annual licensing fee, and go to Bomerk to earn an extra 2 billion a year? The answer is definitely no, because he knows that as the global economy gets better and better, countries will seek more and more hepatitis B vaccines, maybe he will make less money in the first few years, but in a few years, his second plan will earn more, and more importantly, the second plan does not need to be exclusively authorized in the United States, and at that time, Ji Sheng can authorize Futai Pharmaceutical to also sell in the beautiful country.

Even if Merck can quickly launch drugs to seize the market, but Futai Pharmaceutical will definitely be favored by capital because it also has such a technology, not to mention grabbing the market with Merck, and it can't be grabbed normally.

So Ji Sheng prefers Merck to choose the second plan he proposed.

Merck's group of top brass was indeed conquered by the second option.

The only one that makes Roy. Vagelos and the rest of Merck's top brass were puzzled by the billion.

Borrowing a billion dollars all at once? Could it be that there is something wrong with the core point of this technology, so this guy wants to take a billion and run away?

Roy. Vagellos and Allison. Hone and other Merck executives have this idea.

But just when they were puzzled, Ji Sheng took the initiative to say: "As long as you agree, we can sign the contract immediately, and I have brought the complete technical information, you can verify whether it is true and valid on the spot, if so, lend me a billion dollars, if not, you can cancel the contract immediately, and this loan, I only need to use two months, we can even add a clause to the contract, if I don't return the billion dollars after two months, the patent right of this technology will be transferred to Merck, It's exactly two months, and that's enough time for you to produce the first batch of vaccines to seize the market. ”

After signing the contract, you can verify the technology, if the technology is incomplete, they can cancel the contract, the most important thing, if Ji Sheng can't return the billion in two months, the technology patent will belong to Merck!

At this moment, the high-level people on Merck's side couldn't sit still.

"Roy, promise Mr. Ji."

"He's got it all to this point, and there's no reason why we shouldn't say yes."

"Yes, first of all, we have to verify the technology before the contract really takes effect, and secondly, if he can't return a billion dollars in two months, the technology will be ours, agree."

Mason. Randy and Liam. Jack and the others gasped and said, they all wanted to take this technology for themselves immediately.

To everyone's great surprise, Roy. Dr. Vagelos frowned and asked, "Mr. Ji, I've heard that you're going to get a billion dollars today, with all due respect, do you have anything to do with the money?" ”

Alison. Hoin and the others reacted instantly.

That's right.

You have repeatedly said that you want to get a billion dollars today, is it urgent to need money?

If you need money urgently, then you can lower the price.

High!

It's still the chairman of the board!

Mason. Randy and the others were impressed.

Ji Sheng has known about Roy for a long time. Dr. Vagelos would ask, not hiding anything at all: "Yes, I have an important investment that needs a billion dollars in turnover, and if it goes well, the profit could be more than one hundred percent!" ”

Mason. Randy: "......"

Alison. Hoin: "......"

Liam. Jack and others: "......"

They all listened a little stupidly, borrowing a billion dollars to invest, and the profit reached more than 100 percent? Doesn't that mean that you can make a billion guaranteed profits? This group of people couldn't help but take the initiative, and wanted to ask Ji Sheng what investment he was, and then he also followed suit.

Of course, this is just the first thought of everyone, and then the second thought pops up, since you are in a hurry to use the money, we still have to reduce the price?

Roy. Ignoring the glances from his colleagues, Vagelos continued to ask, "May I ask what kind of investment it is?" ”

Ji Sheng said honestly: "I am optimistic that the US dollar will continue to rise in the foreign exchange market and want to invest in the US dollar in the foreign exchange market. ”

When I heard this, everyone was discouraged, and the idea of following the investment disappeared in an instant.

Why?

Because in recent years, the US dollar has been interfered with by various countries, and it is impossible to rise sharply, and even since April, it has fallen a lot.

Just when everyone was thinking about it, Roy. Dr. Vagelos spoke again, "Well, I agreed. ”

Yes?

Doesn't it lower the price?

Merck's top brass was a little confused.

Where did they know, Roy. Vagelos thinks more than they think, since Ji Sheng wants to invest in the US dollar in the foreign exchange market, then with the "recession" of the US dollar in recent years, there is a high probability that he will lose his blood.

Once Ji Sheng loses money in the foreign exchange market, what will happen next?

Needless to say, the billion dollars will definitely not come up, and then the latest hepatitis B vaccine technology will belong to Merck?

Anyone is willing to buy a technology that can make tens of billions of dollars or even hundreds of billions of dollars.

Let's say something unpleasant, not to mention how much money this technology can make in the future, just say that if Merck develops it itself and it is relatively smooth, it will also need to invest more than 2 billion.

Having the opportunity to buy at least more than two billion dollars worth of technology research and development results with one billion dollars, Roy Brown. Why didn't Vagelos say yes? This is much more cost-effective than taking the license at a lower price, provided that the technology is verified to be effective, then again, if it is invalid, Merck will not give Ji Sheng money.

Since this plan is not harmful to Merck Bailey, Roy. Vagelos couldn't think of any reason to refuse, so he agreed to lend a billion to Ji Sheng.

Ji Sheng didn't know about Roy at all. Vagelos had the idea, but when he heard that the other party was willing to take a billion dollars, he suddenly became excited, and he got it, and finally got the money, and he could make more money in the foreign exchange market!

Although the future benefits of the hepatitis B vaccine are sacrificed, if Ji Sheng can make more money now, he can rely on this money combined with the information collected by modern society to quickly earn ten, twenty or even a hundred times more money than the future benefits of the hepatitis B vaccine.

【Yunxi】

(Shortcut: ← Shortcut: Enter Shortcut: →)